查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990212

一般外科醫療設備市場：2026-2032年全球市場預測（依產品類型、技術、產品特性、最終用戶和應用分類）

General Surgery Devices Market by Product Type, Technology, Product Nature, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，一般外科醫療設備市場價值為202.7億美元，預計到2026年將成長至215.1億美元，複合年成長率為6.93%，到2032年將達到324.1億美元。

主要市場統計數據
基準年 2025 202.7億美元
預計年份：2026年 215.1億美元
預測年份：2032年 324.1億美元
複合年成長率 (%) 6.93%

簡要概述技術整合、醫療領域的變化以及採購要求如何改變一般外科醫療設備的決策。

目前一般外科醫療設備的發展趨勢是：技術融合加速、醫療環境不斷變化，以及監管和經濟監控力度加大。外科團隊和採購經理正在適應不斷變化的環境，例如，能量平台和微創手術器械等精準技術正被整合到標準診療流程中，同時醫療服務模式也在逐步將手術從住院病房轉移到門診和診所。這種轉變是由縮短住院時間、降低圍手術全期風險和改善患者體驗等臨床需求所驅動的，從而導致醫療設備的選擇、庫存策略和培訓計劃的重組。

能源平台的發展、醫療保健的去中心化以及監管的加強，是如何從根本上改變競爭動態和臨床工作流程的？

近年來，一般外科醫療設備領域經歷了變革性的變化，這些變化正在改變競爭優勢和臨床管道。能量技術和混合器械的進步使外科醫生能夠更精準地進行止血和組織分離，並減少器械更換的頻率。因此，手術時間得以縮短，手術室物流的複雜性也得以降低。同時，影像引導系統和平台化系統的擴展正在建立一個生態系統，在這個生態系統中，單一供應商的解決方案和可互通的配件正在影響採購行為和資本投資規劃。

評估 2025 年美國關稅調整將如何重塑整個生態系統的供應鏈策略、採購決策和採購風險管理。

美國關稅將於2025年生效並逐步收緊，這為整個普通外科醫療設備生態系統帶來了多層次的複雜性，影響著籌資策略、供應商關係和營運規劃。由於關稅變化會影響進口零件和成品的到貨成本，醫療設備製造商被迫重新審視其供應鏈佈局和與供應商的合約條款。為此，製造商正在進行供應商細分，識別單一採購模式帶來的重大風險，並優先考慮對高風險零件採用雙重採購和本土化生產方案。

一項全面的細分分析，揭示了整個普通外科醫療設備類別中臨床需求、採購偏好和創新投資的交集。

詳細的細分分析闡明了臨床需求、採購偏好和創新投資如何在整個普通外科醫療設備領域相互交織。基於產品特性，市場分析分為電外科器械、腹腔鏡器械、手術縫合器、超音波外科器械及血管封閉器械。在手術縫合器方面，手動縫合器和電動縫合器之間存在顯著差異，分別適用於不同的手術流程和使用者人體工學需求。基於終端使用者需求模式，市場細分為門診手術中心、診所和醫院，每種機構對器械尺寸、消毒流程和服務期望的要求各不相同。依適應症分類，臨床重點領域包括盲腸切除手術、減重手術、結直腸手術、膽囊切除術和疝氣修補術。在減重手術中，每種手術亞型，例如可調式胃束帶術、胃繞道手術和袖狀切除術，都有其獨特的器械和縫合線的考量，這些考量會影響產品開發和培訓需求。

針對特定區域的洞察揭示了監管差異、醫療保健服務模式和採購重點如何影響市場策略和產品策略。

區域趨勢持續影響產品策略和市場進入方式，反映出全球市場在管理體制、醫療服務模式和資本基礎設施方面的差異。在美洲，成本控制和可驗證的臨床療效是醫療體系的重中之重，推動了對能夠提高效率和提供可預測服務經濟性的醫療設備的需求。此外，該地區某些手術的門診模式應用廣泛，這也影響了包裝、便攜性和滅菌設計的考量。

產品平台、證據產生和服務可靠性如何推動領先的醫療設備製造商之間的競爭差異化和夥伴關係策略？

一般外科醫療設備領域的競爭趨勢呈現出多方面的差異化，涵蓋創新、臨床證據和服務交付。主要企業正投資於平台策略，將手術器械與專有耗材和數位化工具相結合，以提升外科醫生的手術體驗並創造永續的收入來源。同時，專業製造商正利用特定解剖結構和手術流程的需求，提供針對特定應用和外科醫生偏好的高性能手術器械。策略聯盟和有針對性的收購在填補產品系列空白、加速獲取互補技術以及最佳化全球分銷網路方面繼續發揮著至關重要的作用。

為製造商提供可操作的策略步驟，以調整模組化產品開發、證據計劃和彈性供應鏈，從而與不斷變化的臨床和採購重點相符。

產業領導企業應優先考慮一系列切實可行的舉措，旨在使產品開發、商業策略和供應鏈韌性與不斷變化的臨床和經濟現實相適應。首先，投資於模組化產品架構和可互通的配件，以降低單次手術成本並簡化培訓。這種方法支援在醫院、門診中心和診所的部署，從而避免需要多種設備系列的情況。其次，制定全面的循證研究計劃，將隨機數據與可操作的真實世界結果相結合，以證明其臨床價值，並為與大規模醫療系統和綜合醫療網路進行合約談判奠定堅實的基礎。

我們採用嚴謹的混合方法研究，結合相關人員訪談、臨床文獻回顧和供應鏈情境分析，確保獲得可操作且令人信服的見解。

支持這些發現的研究整合了定性專家訪談、與關鍵相關人員的諮詢以及對臨床文獻、監管指令和供應鏈資訊披露的嚴格審查。主要研究包括與醫院、門診部和私人診所的外科醫生、採購經理、臨床工程師和銷售經理進行結構化討論，以檢驗技術應用促進因素、流程和預期服務。次要研究整合了同行評審的臨床研究、監管指南和製造商技術文檔，以揭示技術能力和安全性概況。

綜合結論強調，創新、證據和供應鏈韌性的協調一致決定了誰能獲得臨床信任和市場支持。

總而言之，技術進步、醫療保健分散化以及影響採購和臨床應用的經濟壓力正在重塑普通外科醫療設備的市場格局。基於能源的平台、微創手術器械和模組化器械架構的融合正在提高手術效率和病患療效，而關稅和供應鏈趨勢則促使人們重新評估採購和製造策略。需要針對特定市場採取相應的策略，以應對監管的嚴格性和醫療服務模式的區域差異。從產品特性、最終用戶、應用、技術、分銷管道和產品性質等方面進行細分，可以明確投資和商業化工作的重點領域，從而最大限度地發揮影響力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：通用外科醫療設備市場：依產品特性分類

  • 電外科設備
  • 腹腔鏡器械
  • 手術縫合器
    • 手動訂書機
    • 電動訂書機
  • 超音波手術設備
  • 血管密封裝置

第9章：通用外科醫療設備市場：依技術分類

  • 雷射
  • 機械的
  • 高頻
  • 超音波

第10章 普通外科醫療設備市場：依產品特性分類

  • 一次性的
  • 可重複使用的

第11章 普通外科醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章 普通外科醫療設備市場：依應用領域分類

  • 盲腸切除手術
  • 減重手術
    • 可調式胃束帶手術
    • 胃繞道手術
    • 袖狀切除術
  • 大腸直腸/直腸手術
  • 膽囊切除術
  • 疝氣修補術

第13章：普通外科醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 普通外科醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 普通外科醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國一般外科醫療設備市場

第17章：中國普通外科醫療設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Cardinal Health, Inc.
  • Carl Zeiss Meditec AG
  • CooperSurgical, Inc.
  • Delta Med SpA
  • Ecolab Inc.
  • Globus Medical, Inc.
  • Henry Schein, Inc.
  • Innomed, Inc.
  • Johnson & Johnson Services Inc
  • Koninklijke Philips NV
  • Medica Europe BV
  • Medtronic PLC
  • Olympus Corporation
  • Schott AG
  • Siemens Healthcare GmbH
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: MRR-99555D55052D

The General Surgery Devices Market was valued at USD 20.27 billion in 2025 and is projected to grow to USD 21.51 billion in 2026, with a CAGR of 6.93%, reaching USD 32.41 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.27 billion
Estimated Year [2026] USD 21.51 billion
Forecast Year [2032] USD 32.41 billion
CAGR (%) 6.93%

A concise overview of how technological convergence, shifting care settings, and procurement imperatives are reshaping decision-making across general surgery devices

The contemporary landscape for general surgery devices is defined by accelerating technological convergence, shifting care settings, and heightened regulatory and economic scrutiny. Surgical teams and procurement leaders are navigating an environment where precision technologies such as energy-based platforms and minimally invasive instrumentation are being integrated into standard practice, while healthcare delivery models progressively migrate procedures away from inpatient wards toward ambulatory and clinic environments. This transition is driven by clinical priorities to reduce length of stay, mitigate perioperative risk, and improve patient experience, and it is reshaping device selection, inventory strategies, and training programs.

Importantly, providers are balancing clinical performance with total cost of ownership, creating stronger demand signals for device modularity, interoperability, and consumable efficiency. At the same time, device manufacturers are responding by prioritizing user-centered design, evidence generation, and lifecycle support to differentiate within competitive tenders. As stakeholders adapt to these dynamics, strategic decision-making requires a nuanced appreciation of technology adoption patterns, end-user preferences, and the regulatory and reimbursement ecosystems that collectively determine product trajectory and clinical uptake.

How advances in energy-based platforms, care decentralization, and regulatory scrutiny are fundamentally transforming competitive dynamics and clinical workflows

Over recent years the landscape of general surgery devices has experienced transformative shifts that are altering competitive advantage and clinical pathways. Advances in energy-based technologies and hybrid instrumentation are enabling surgeons to achieve hemostasis and tissue division with greater precision and fewer instrument exchanges, which in turn reduces operative time and the complexity of OR logistics. Concurrently, the expansion of image-guided and platform-based systems has fostered an ecosystem where single-vendor solutions and cross-compatible accessories influence purchasing behavior and capital planning.

Moreover, organizational strategy is being influenced by decentralization of care: ambulatory surgical centers and outpatient clinics are increasing procedural volume for select general surgery indications, prompting suppliers to introduce compact, cost-effective devices optimized for smaller footprints. Regulatory updates and heightened post-market surveillance have elevated the need for robust safety data and traceability, prompting manufacturers to invest in clinical studies and digital post-market monitoring. Collectively, these shifts favor manufacturers that can demonstrate clinical differentiation, supply reliability, and responsive service models, while health systems are increasingly prioritizing partners who support value-based care initiatives and operational resilience.

Assessment of how 2025 United States tariff adjustments are reshaping supply chain strategies, sourcing decisions, and procurement risk management across the ecosystem

The introduction and escalation of United States tariff measures in 2025 have introduced a layered complexity that affects sourcing strategies, supplier relationships, and operational planning across the general surgery devices ecosystem. Tariff changes influence landed costs for imported components and finished devices, which has prompted device companies to reassess their supply chain footprints and contractual terms with suppliers. In response, manufacturers are conducting supplier segmentation exercises to identify critical single-source exposures and to prioritize dual-sourcing or onshoring options for high-risk components.

Consequently, procurement teams and commercial leaders are revisiting pricing strategies and negotiating longer-term agreements that include price adjustment mechanisms and shared risk provisions. Importantly, the tariffs have accelerated conversations about vertical integration for certain consumables and subassemblies, while simultaneously incentivizing investment in regional manufacturing capabilities to reduce exposure to cross-border tariff volatility. From the provider perspective, hospitals and ambulatory centers are increasingly scrutinizing total procurement costs and supplier service levels, favoring manufacturers that can demonstrate nimble supply continuity plans and transparent cost structures. Moving forward, stakeholders must factor in tariff-related operational contingencies when modeling procurement cycles and capital acquisitions to preserve margin and patient access.

Comprehensive segmentation analysis revealing where clinical demand, procurement preferences, and innovation investments intersect across the general surgery devices category

A granular view of segmentation provides clarity on where clinical demand, procurement preferences, and innovation investments converge across the general surgery devices category. Based on product type the market is examined through electrosurgical devices, laparoscopic instruments, surgical staplers, ultrasonic surgical devices, and vessel sealing devices; within surgical staplers an important distinction exists between manual staplers and powered staplers, each addressing different procedural workflows and user ergonomics. Based on end user demand patterns are differentiated across ambulatory surgical centers, clinics, and hospitals, with each setting generating distinct requirements for device size, sterilization workflows, and service expectations. Based on application clinical focus areas include appendectomy, bariatric surgery, colorectal surgery, gallbladder removal, and hernia repair; within bariatric surgery, procedural subtypes such as adjustable gastric banding, gastric bypass, and sleeve gastrectomy present unique instrumentation and staple-line considerations that influence product development and training needs.

Based on technology the landscape is segmented across laser, mechanical, radiofrequency, and ultrasonic modalities, each offering particular advantages in tissue effect, thermal spread, and user adoption curves. Based on distribution channel commercial pathways vary across direct sales models, distributor sales, and online platforms, affecting margin structures, market reach, and post-sale support. Lastly, based on product nature devices are categorized as disposable or reusable, which has implications for procurement cycles, environmental considerations, and clinical preference. Synthesizing these segmentation lenses highlights where innovation investment, commercialization strategy, and clinical evidence generation should be concentrated to capture distinct use-case value and to align product roadmaps with end-user workflows.

Region-specific insights that clarify how regulatory variation, care delivery models, and procurement priorities influence market approach and product strategy

Regional dynamics continue to shape product strategy and go-to-market approaches, reflecting divergent regulatory regimes, care delivery models, and capital infrastructure across global markets. In the Americas, healthcare systems place a premium on cost containment and demonstrable clinical outcomes, driving demand for devices that deliver efficiency gains and predictable service economics. This region also demonstrates strong adoption of ambulatory care models for select procedures, which informs packaging, portability, and sterilization design considerations.

In Europe, Middle East & Africa the regulatory landscape is heterogeneous, with varying approval timelines and reimbursement pathways that necessitate tailored market entry and evidence strategies; providers in this region frequently emphasize clinical safety and long-term durability when selecting devices. Meanwhile, the Asia-Pacific region exhibits pronounced heterogeneity in hospital capacity, procedure volumes, and investment in surgical infrastructure, creating opportunities for scalable, cost-effective technologies as well as the need for localized training and service networks. Across all regions, stakeholders are increasingly evaluating environmental policies and lifecycle impacts of disposable versus reusable devices, which in turn influences procurement frameworks and supplier selection. Taken together, these regional insights should guide manufacturers in prioritizing regulatory investments, distribution partnerships, and customer support models that reflect local practice patterns and institutional priorities.

How product platforms, evidence generation, and service reliability are driving competitive differentiation and partnership strategies among leading device manufacturers

Competitive dynamics within the general surgery devices sector are characterized by multi-dimensional differentiation across innovation, clinical evidence, and service delivery. Leading firms are investing in platform strategies that bundle instruments with proprietary consumables and digital tools to enhance surgeon experience and to create recurring revenue streams. At the same time, specialized manufacturers are capitalizing on niche anatomical and procedural requirements, delivering high-performance instruments tailored to specific applications and surgeon preferences. Strategic partnerships and targeted acquisitions continue to play a role in filling portfolio gaps, accelerating access to complementary technologies, and optimizing global distribution networks.

Service excellence and supply reliability are emerging as significant differentiators, particularly for customers operating across ambulatory centers and decentralized care settings where inventory and sterilization capacity may be constrained. Additionally, firms that proactively engage in real-world evidence generation and post-market surveillance secure stronger clinical adoption and payer acceptance. For market entrants, success depends on clear value propositions, nimble commercialization models, and credible clinical champions to support adoption. Established players must focus on sustaining innovation pipelines while streamlining operations to defend against margin pressure and evolving procurement modalities.

Actionable strategic moves for manufacturers to align modular product development, evidence programs, and resilient supply chains with shifting clinical and procurement priorities

Industry leaders should prioritize a set of actionable initiatives designed to align product development, commercial strategy, and supply chain resilience with evolving clinical and economic realities. First, invest in modular product architectures and interoperable accessories that reduce per-procedure costs and simplify training; this approach supports adoption across hospitals, ambulatory centers, and clinics and mitigates the need for multiple device families. Next, develop comprehensive evidence-generation programs that combine randomized data with pragmatic real-world outcomes to demonstrate clinical value and support favorable contracting conversations with large health systems and integrated delivery networks.

Simultaneously, strengthen supply chain resilience by diversifying suppliers, negotiating flexible long-term agreements, and exploring regional manufacturing options to reduce exposure to tariff and logistics volatility. Enhance post-sale value by offering bundled service packages, remote training, and data-driven maintenance programs that reduce downtime and improve customer satisfaction. Finally, align commercialization channels by balancing direct sales capabilities with distributor partnerships and digital platforms to maximize reach while preserving margin. Implementing these recommendations will enable companies to accelerate adoption, protect margin, and adapt to shifting care models and regulatory expectations.

A rigorous mixed-methods research approach combining stakeholder interviews, clinical literature review, and supply chain scenario analysis to ensure actionable and defensible insights

The research underpinning these insights integrates qualitative expert interviews, primary stakeholder consultations, and a rigorous review of clinical literature, regulatory communications, and supply chain disclosures. Primary research included structured discussions with surgeons, procurement directors, clinical engineers, and commercial leaders across hospital, ambulatory, and clinic settings to validate adoption drivers, procedural workflows, and service expectations. Secondary analysis synthesized peer-reviewed clinical studies, regulatory guidance, and manufacturer technical documentation to map technology capabilities and safety profiles.

Analytical frameworks employed scenario analysis, supplier risk mapping, and segmentation overlays to interpret how tariffs, regional regulatory differences, and distribution channels interact with product adoption. Triangulation methods were used to reconcile qualitative insights with documented evidence, ensuring that conclusions reflect both lived clinical experience and published data. Throughout the process, attention was paid to data provenance, potential bias in self-reported supplier performance, and the need for transparent assumptions when interpreting supply chain impacts. This methodology supports robust, actionable findings while maintaining clarity on evidence sources and analytical limitations.

A synthesized conclusion emphasizing how alignment of innovation, evidence, and supply chain resilience will determine who captures clinical trust and market preference

In summary, the general surgery devices landscape is being reshaped by technological evolution, decentralization of care, and economic pressures that together influence procurement and clinical adoption. Energy-based platforms, minimally invasive instrumentation, and modular device architectures are converging to deliver improved operative efficiency and patient outcomes, while tariffs and supply chain dynamics are prompting reassessments of sourcing and manufacturing strategies. Regional variations in regulatory rigor and care delivery models require tailored market approaches, and segmentation across product type, end user, application, technology, distribution channel, and product nature highlights where targeted investment and commercialization focus will yield the greatest impact.

Going forward, manufacturers and healthcare providers that prioritize interoperability, evidence generation, and supply chain resilience will be best positioned to capture clinical trust and operational preference. By aligning product roadmaps with institutional needs and by investing in service models that reduce adoption friction, stakeholders can translate innovation into measurable clinical and economic value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. General Surgery Devices Market, by Product Type

  • 8.1. Electrosurgical Devices
  • 8.2. Laparoscopic Instruments
  • 8.3. Surgical Staplers
    • 8.3.1. Manual Staplers
    • 8.3.2. Powered Staplers
  • 8.4. Ultrasonic Surgical Devices
  • 8.5. Vessel Sealing Devices

9. General Surgery Devices Market, by Technology

  • 9.1. Laser
  • 9.2. Mechanical
  • 9.3. Radiofrequency
  • 9.4. Ultrasonic

10. General Surgery Devices Market, by Product Nature

  • 10.1. Disposable
  • 10.2. Reusable

11. General Surgery Devices Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Clinic
  • 11.3. Hospital

12. General Surgery Devices Market, by Application

  • 12.1. Appendectomy
  • 12.2. Bariatric Surgery
    • 12.2.1. Adjustable Gastric Banding
    • 12.2.2. Gastric Bypass
    • 12.2.3. Sleeve Gastrectomy
  • 12.3. Colorectal Surgery
  • 12.4. Gallbladder Removal
  • 12.5. Hernia Repair

13. General Surgery Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. General Surgery Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. General Surgery Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States General Surgery Devices Market

17. China General Surgery Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Abbott Laboratories
  • 18.7. B. Braun Melsungen AG
  • 18.8. Becton, Dickinson, and Company
  • 18.9. Cardinal Health, Inc.
  • 18.10. Carl Zeiss Meditec AG
  • 18.11. CooperSurgical, Inc.
  • 18.12. Delta Med S.p.A.
  • 18.13. Ecolab Inc.
  • 18.14. Globus Medical, Inc.
  • 18.15. Henry Schein, Inc.
  • 18.16. Innomed, Inc.
  • 18.17. Johnson & Johnson Services Inc
  • 18.18. Koninklijke Philips N.V.
  • 18.19. Medica Europe B.V.
  • 18.20. Medtronic PLC
  • 18.21. Olympus Corporation
  • 18.22. Schott AG
  • 18.23. Siemens Healthcare GmbH
  • 18.24. Smith & Nephew PLC
  • 18.25. Stryker Corporation
  • 18.26. Teleflex Incorporated
  • 18.27. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GENERAL SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GENERAL SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY POWERED STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY POWERED STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY VESSEL SEALING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY VESSEL SEALING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY VESSEL SEALING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPENDECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPENDECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPENDECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GALLBLADDER REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GALLBLADDER REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GALLBLADDER REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 158. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)